Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response

Autor: Stefanovic F, Gomez-Caminero A, Jacobs DM, Subramanian P, Puzanov I, Chilbert MR, Feuerstein SG, Yatsynovich Y, Switzer B, Schentag JJ

Publikováno v: Clinical Pharmacology: Advances and Applications, Vol Volume 14, Pp 69-90 (2022)

Filip Stefanovic,1,2 Andres Gomez-Caminero,3 David M Jacobs,2,4 Poornima Subramanian,2 Igor Puzanov,5,6 Maya R Chilbert,4 Steven G Feuerstein,4 Yan Yatsynovich,6,7 Benjamin Switzer,5 Jerome J Schentag2,4,5 1Department of Biomedical Engineering, Unive

Externí odkaz: https://doaj.org/article/2d4fcbba320645739afcea98af7db00b

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis.

Autor: Puzanov I; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA igor.puzanov@roswellpark.org., Subramanian P; CPL Associates, Buffalo, New York, USA., Yatsynovich YV; Department of Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA., Jacobs DM; CPL Associates, Buffalo, New York, USA.; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA., Chilbert MR; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA., Sharma UC; Department of Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA., Ito F; Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Department of Surgery, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY, USA., Feuerstein SG; CPL Associates, Buffalo, New York, USA.; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA., Stefanovic F; CPL Associates, Buffalo, New York, USA.; Department of Biomedical Engineering, University at Buffalo School of Engineering and Applied Sciences, Buffalo, New York, USA., Switzer B; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Hicar MD; Department of Pediatrics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA., Curtis AB; Department of Medicine, University at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, USA., Spangenthal EJ; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Dy GK; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Ernstoff MS; Division of Cancer Treatment and Diagnosis/Developmental Therapeutics Program, National Cancer Institute, Rockville, Maryland, USA., Vachhani P; Department of Medicine, Division of Hematology and Oncology, The University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, USA., Page BJ; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA., Agrawal N; Department of Cardiovascular Medicine, The University of Texas at Houston/MD Anderson Cancer Center, Houston, Texas, USA., Khunger A; Department of Internal Medicine, Memorial Hospital West, Pembroke Pines, Florida, USA., Kapoor A; Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA., Hattoum A; Department of Cardiovascular Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA., Schentag JJ; CPL Associates, Buffalo, New York, USA.; Department of Pharmacy Practice, University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York, USA.

Publikováno v: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jun; Vol. 9 (6).